Citations 1
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
Bekaii-Saab, Tanios S , Rimassa, Lorenza , Furuse, Junji , Ioka, Tatsuya , Macarulla, Teresa , Wasan, Harpreet , Jiang, Ping , Lihou, Christine , Asatiani, Ekaterine, Féliz, Luis , Vogel, Arndt , Bekaii‐Saab, Tanios , Bekaii-Saab, Tanios S , Macarulla, Teresa , Rimassa, Lorenza , Vogel, Arndt , Bekaii-Saab, Tanios S , Valle, Juan W. , Cutsem, Eric Van , Furuse, Junji , Melisi, Davide , Bridgewater, John , Borad, Mitesh J. , Abou‐Alfa, Ghassan K. , Zhen, Huiling
Future Oncology | July 17, 2020 | Volume: 16 | Issue: 30 | Pages: 2385-2399
